Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

DNA Hypermethylation as a Blood-Based Marker for Pancreatic Cancer: A Literature Review.

Pancreas - 1 Oct 2015

Henriksen Stine Dam, Madsen Poul Henning, Krarup Henrik, Thorlacius-Ussing Ole

Abstract excerpt

OBJECTIVES: The aim is to review genes aberrantly methylated in pancreatic cancer. This review focuses on DNA promoter hypermethylation in plasma and serum to describe the most promising genes that may be useful as minimally invasive diagnostic blood-based markers for pancreatic cancer. METHODS: A systematic search of the literature was performed using the PubMed and EMBASE databases. The following MeSH terms and...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Biomarkers, Tumor
Share to CpG Islands
Share to DNA Methylation

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Genetic Predisposition to Disease

Share to Pancreatic and Hepatic Oncology Research

Share to Pancreatic Neoplasms

Share to Promoter Regions, Genetic

Share to Sensitivity and Specificity

Source

Identifiers

PMID: 26355546
DOI: 10.1097/MPA.0000000000000487

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-07.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

DNA Hypermethylation as a Blood-Based Marker for Pancreatic Cancer: A Literature Review.PMID 26355546Read ↗

Cell-Free DNA Methylation as Blood-Based Biomarkers for Pancreatic Adenocarcinoma—A Literature UpdateSemantic proximity Read ↗

Cell-free DNA promoter hypermethylation in plasma as a predictive marker for survival of patients with pancreatic adenocarcinomaSemantic proximity Read ↗

Deciphering DNA methylation signatures of pancreatic cancer and pancreatitisSemantic proximity Read ↗

Methylation profile of circulating plasma DNA in patients with pancreatic cancerSemantic proximity Read ↗

Molecular detection of pancreatic neoplasia: Current status and future promise.Semantic proximity Read ↗

Preliminary Study Analyzing the Methylated Genes in the Plasma of Patients with Pancreatic CancerSemantic proximity Read ↗

Characterizing DNA methylation patterns in pancreatic cancer genomeSemantic proximity Read ↗

Genome-Wide Analysis of Cell-Free DNA Methylation Profiling for the Early Diagnosis of Pancreatic CancerSemantic proximity Read ↗

Promoter hypermethylation in plasma‐derived cell‐free DNA as a prognostic marker for pancreatic adenocarcinoma stagingSemantic proximity Read ↗

Cell-Free DNA Methylation: The New Frontiers of Pancreatic Cancer Biomarkers’ DiscoverySemantic proximity Read ↗

Methylation-based Cell-free DNA Signature for Early Detection of Pancreatic CancerSemantic proximity Read ↗

Circulating Cell-Free Tumour DNA for Early Detection of Pancreatic CancerSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.